| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Abstract
Summary
This report is an essential source for in-depth information and data relating
to the Belgium Diabetes Care Devices devices market. It also offers detailed
and comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the Diabetes Care Devices in
Belgium.
Scope
• The report provides diabetes care devices information broken down into
detailed categories and segments in Belgium.
• Total revenues, products
sold, end users, and average pricing.
• Market shares of all the key
competitors.
• Key pipeline products that are set to shape the market,
broken down by sector.
• Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
• Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
• Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
• Customer, hospitals and physicians data.
Reasons to buy
• Gain a strong understanding of the diabetes care devices market in
Belgium.
• Evaluate and compare the attractiveness of the market in the
country.
• Identify growth segments and opportunities in each industry
sector within the country.
• Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
• Analyze the competitiveness of the
market in the country and identify hotspots.
• Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
• Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
• Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
TABLE OF CONTENTS
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2
Introduction 11
2.1 What Is This Report About? 11
2.2 Definitions
11
3 Healthcare Sector Review 13
3.1 Healthcare Expenditure 13
3.2
Healthcare Infrastructure 14
3.3 Healthcare Policy 18
4 Diabetes Care
Devices in Belgium 20
4.1 Diabetes Care Devices Overall Revenues
(2000-2012) 20
4.2 Diabetes Care Devices Overall Volume (2000-2012) 26
4.3 Diabetes Care Devices Overall Company Share (2006-2007) 29
5 Glucose
Monitoring in Belgium 30
5.1 Glucose Monitoring Overall Revenues
(2000-2012) 30
5.2 Glucose Monitoring Overall Volume (2000-2012) 38
5.3 Glucose Monitoring Average Price (2000-2012) 44
5.4 Glucose Monitoring
Distribution Share (2006-2007) 48
5.5 Glucose Monitoring Company Share
(2006-2007) 49
6 Insulin Delivery Belgium 50
6.1 Insulin Delivery
Overall Revenues (2000-2012) 50
6.2 Insulin Delivery Overall Volume
(2000-2012) 60
6.3 Insulin Delivery Average Price (2000-2012) 67
6.4
Insulin Delivery Distribution Share (2006-2007) 73
6.5 Insulin Delivery
Company Share (2006-2007) 74
7 F. Hoffmann-La Roche Ltd. Company Profile
75
7.1 Company Overview 75
7.2 Business Overview 75
7.3 Value
Chain Analysis 80
7.4 SWOT Analysis 83
7.5 Financial and Operational
Review 87
7.6 Locations And Subsidiaries 89
7.7 Financial Deals
Landscape 90
7.8 Recent Developments 146
8 LifeScan, Inc. Company
Profile 159
8.1 Company Overview 159
8.2 Business Overview 159
8.3
Locations And Subsidiaries 161
8.4 Recent Developments 162
8.5
LifeScan, Inc. Pipeline Products 162
9 Abbott Laboratories Company Profile
165
9.1 Company Overview 165
9.2 Business Overview 165
9.3 Value
Chain Analysis 170
9.4 SWOT Analysis 173
9.5 Financial and Operational
Review 177
9.6 Locations and Subsidiaries 179
9.7 Financial Deals
Landscape 180
9.8 Recent Developments 208
9.9 Abbott Laboratories
Pipeline Products 219
10 Novo Nordisk A/S Company Profile 227
10.1
Company Overview 227
10.2 Business Overview 227
10.3 Locations and
Subsidiaries 229
10.4 Recent Developments 231
10.5 Novo Nordisk A/S
Pipeline Products 238
11 Bayer HealthCare AG Company Profile 241
11.1
Company Overview 241
11.2 Business Overview 241
11.3 Value Chain
Analysis 247
11.4 SWOT Analysis 249
11.5 Locations and Subsidiaries
252
11.6 Financial Deals Landscape 253
11.7 Recent Developments
257
11.8 Bayer HealthCare AG Pipeline Products 264
12 Regulation
System 269
12.1 Medical Equipment Approval Process 269
12.2
Notification Fee 283
13 Pricing and Reimbursement 284
13.1
Reimbursement Policies 284
14 Distribution Structure 285
15 Appendix
286
15.1 Global Markets Direct Research Methodology 286
15.2 Coverage
287
15.3 Secondary Research 287
15.4 Primary Research 288
15.5
Models 288
15.6 Forecasts 289
15.7 Expert Panels 289
15.8 Currency
Conversion 290
15.9 Contact Us 291
15.10 Disclaimer 291
1.1 List of Tables
Table 1: Hospitals and Hospital Beds in Belgium,
2005 23
Table 2: Number of Doctors by Specialty in Belgium, 2003-2007
24
Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007
25
Table 4: Diabetes Care Devices, Belgium, Overall Revenues ($ mn),
2000-2012 28
Table 5: Diabetes Care Devices, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 29
Table 6: Diabetes Care Devices, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 30
Table 7: Diabetes Care
Devices, Belgium, Overall Revenues ($ mn), 2000-2012 31
Table 8: Diabetes
Care Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 32
Table 9: Diabetes Care Devices, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 33
Table 10: Diabetes Care Devices, Belgium, Overall Volume
(Units), 2000-2012 34
Table 11: Diabetes Care Devices, Belgium, Overall
Volume (Units), Historic, 2000-2007 35
Table 12: Diabetes Care Devices,
Belgium, Overall Volume (Units), Forecast, 2007-2012 36
Table 13: Diabetes
Care Devices, Belgium, Overall Company Share by Revenue ($ mn), 2006-2007
37
Table 14: Glucose Monitoring, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 38
Table 15: Glucose Monitoring, Belgium, Overall
Revenues ($ mn), Forecast, 2007-2012 39
Table 16: Glucose Monitoring,
Belgium, Revenue by Segment ($ mn), Historic, 2000-2007 40
Table 17:
Glucose Monitoring, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012
41
Table 18: Blood Glucose Test Strips, Belgium, Revenues ($ mn),
Historic, 2000-2007 42
Table 19: Blood Glucose Test Strips, Belgium,
Revenues ($ mn), Forecast, 2007-2012 43
Table 20: Blood Glucose Meters,
Belgium, Revenues ($ mn), Historic, 2000-2007 44
Table 21: Blood Glucose
Meters, Belgium, Revenues ($ mn), Forecast, 2007-2012 45
Table 22: Glucose
Monitoring, Belgium, Overall Volume (Units), Historic, 2000-2007 46
Table
23: Glucose Monitoring, Belgium, Overall Volume (Units), Forecast, 2007-2012
47
Table 24: Blood Glucose Test Strips, Belgium, Volume (Units), Historic,
2000-2007 48
Table 25: Blood Glucose Test Strips, Belgium, Volume (Units),
Forecast, 2007-2012 49
Table 26: Blood Glucose Meters, Belgium, Volume
(Units), Historic, 2000-2007 50
Table 27: Blood Glucose Meters, Belgium,
Volume (Units), Forecast, 2007-2012 51
Table 28: Blood Glucose Meters,
Belgium, Average Price ($), Historic, 2000-2007 52
Table 29: Blood Glucose
Meters, Belgium, Average Price ($), Forecast, 2007-2012 53
Table 30: Blood
Glucose Test Strips, Belgium, Average Price ($), Historic, 2000-2007 54
Table 31: Blood Glucose Test Strips, Belgium, Average Price ($), Forecast,
2007-2012 55
Table 32: Glucose Monitoring, Belgium, Distribution Share by
Revenue ($ mn), 2006-2007 56
Table 33: Glucose Monitoring, Belgium,
Company Share by Revenue ($ mn), 2006-2007 57
Table 34: Insulin Delivery,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 58
Table 35: Insulin
Delivery, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 59
Table
36: Insulin Delivery, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007
60
Table 37: Insulin Delivery, Belgium, Revenue by Segment ($ mn),
Forecast, 2007-2012 61
Table 38: Insulin Pens, Belgium, Revenues ($ mn),
Historic, 2000-2007 62
Table 39: Insulin Pens, Belgium, Revenues ($ mn),
Forecast, 2007-2012 63
Table 40: Insulin Pumps, Belgium, Revenues ($ mn),
Historic, 2000-2007 64
Table 41: Insulin Pumps, Belgium, Revenues ($ mn),
Forecast, 2007-2012 65
Table 42: Insulin Syringes, Belgium, Overall
Revenues ($ mn), Historic, 2000-2007 66
Table 43: Insulin Syringes,
Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 67
Table 44: Insulin
Delivery, Belgium, Overall Volume (Units), Historic, 2000-2007 68
Table
45: Insulin Delivery, Belgium, Overall Volume (Units), Forecast, 2007-2012
68
Table 46: Insulin Syringes, Belgium, Volume (Units), Historic,
2000-2007 69
Table 47: Insulin Syringes, Belgium, Volume (Units),
Forecast, 2007-2012 70
Table 48: Insulin Pens, Belgium, Volume (Units),
Historic, 2000-2007 71
Table 49: Insulin Pens, Belgium, Volume (Units),
Forecast, 2007-2012 72
Table 50: Insulin Pumps, Belgium, Volume (Units),
Historic, 2000-2007 73
Table 51: Insulin Pumps, Belgium, Volume (Units),
Forecast, 2007-2012 74
Table 52: Insulin Pens, Belgium, Average Price ($),
Historic, 2000-2007 75
Table 53: Insulin Pens, Belgium, Average Price ($),
Forecast, 2007-2012 76
Table 54: Insulin Pumps, Belgium, Average Price
($), Historic, 2000-2007 77
Table 55: Insulin Pumps, Belgium, Average
Price ($), Forecast, 2007-2012 78
Table 56: Insulin Syringes, Belgium,
Average Price ($), Historic, 2000-2007 79
Table 57: Insulin Syringes,
Belgium, Average Price ($), Forecast, 2007-2012 80
Table 58: Insulin
Delivery, Belgium, Distribution Share by Revenue ($ mn), 2006-2007 81
Table 59: Insulin Delivery, Belgium, Company Share by Revenue ($ mn),
2006-2007 82
Table 60: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2006
91
Table 61: F. Hoffmann-La Roche Ltd., Financial Statements, CHF
Million, 2002-2006 95
Table 62: F. Hoffmann-La Roche Ltd., Financial
Ratios, CHF Million, 2002-2006 96
Table 63: F. Hoffmann-La Roche
Ltd., Other Locations 97
Table 63: F. Hoffmann-La Roche Ltd., Other
Locations(Contd..) 98
Table 64: F. Hoffmann-La Roche Ltd.,
Subsidiaries 98
Table 65: LifeScan, Inc., Other Locations 169
Table 66: Abbott Laboratories, SWOT Analysis, 2006 181
Table 67:
Abbott Laboratories, Financial Statements, USD Thousand, 2002-2006 185
Table 68: Abbott Laboratories, Financial Ratios, USD Thousand, 2002-2006
186
Table 69: Abbott Laboratories, Other Locations 187
Table 70:
Abbott Laboratories, Subsidiaries 188
Table 71: Novo Nordisk A/S,
Other Locations 237
Table 72: Novo Nordisk A/S, Subsidiaries 238
Table 73: Bayer HealthCare AG, SWOT Analysis 257
Table 74: Bayer
HealthCare AG, Other Locations 260
Table 75: Medical Equipment
Notification Fee in Belgium, 2007 291
Table 76: Currency Conversion from
USD to Local Currency at 2007 Constant Rate 298
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in Belgium, 2000 -- 2006
22
Figure 2: Structure of Healthcare System in Belgium, 2007 27
Figure
3: Diabetes Care Devices, Belgium, Overall Revenues ($ mn), 2000-2012 28
Figure 4: Diabetes Care Devices, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 29
Figure 5: Diabetes Care Devices, Belgium, Overall Revenues ($
mn), Forecast, 2007-2012 30
Figure 6: Diabetes Care Devices, Belgium,
Overall Revenues ($ mn), 2000-2012 31
Figure 7: Diabetes Care Devices,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 32
Figure 8:
Diabetes Care Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
33
Figure 9: Diabetes Care Devices, Belgium, Overall Volume (Units),
2000-2012 34
Figure 10: Diabetes Care Devices, Belgium, Overall Volume
(Units), Historic, 2000-2007 35
Figure 11: Diabetes Care Devices, Belgium,
Overall Volume (Units), Forecast, 2007-2012 36
Figure 12: Diabetes Care
Devices, Belgium, Overall Company Share (%), 2007 37
Figure 13: Glucose
Monitoring, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 38
Figure 14: Glucose Monitoring, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 39
Figure 15: Glucose Monitoring, Belgium, Revenue by Segment ($
mn), Historic, 2000-2007 40
Figure 16: Glucose Monitoring, Belgium,
Revenue by Segment ($ mn), Forecast, 2007-2012 41
Figure 17: Blood Glucose
Test Strips, Belgium, Revenues ($ mn), Historic, 2000-2007 42
Figure 18:
Blood Glucose Test Strips, Belgium, Revenues ($ mn), Forecast, 2007-2012
43
Figure 19: Blood Glucose Meters, Belgium, Revenues ($ mn), Historic,
2000-2007 44
Figure 20: Blood Glucose Meters, Belgium, Revenues ($ mn),
Forecast, 2007-2012 45
Figure 21: Glucose Monitoring, Belgium, Overall
Volume (Units), Historic, 2000-2007 46
Figure 22: Glucose Monitoring,
Belgium, Overall Volume (Units), Forecast, 2007-2012 47
Figure 23: Blood
Glucose Test Strips, Belgium, Volume (Units), Historic, 2000-2007 48
Figure 24: Blood Glucose Test Strips, Belgium, Volume (Units), Forecast,
2007-2012 49
Figure 25: Blood Glucose Meters, Belgium, Volume (Units),
Historic, 2000-2007 50
Figure 26: Blood Glucose Meters, Belgium, Volume
(Units), Forecast, 2007-2012 51
Figure 27: Blood Glucose Meters, Belgium,
Average Price ($), Historic, 2000-2007 52
Figure 28: Blood Glucose Meters,
Belgium, Average Price ($), Forecast, 2007-2012 53
Figure 29: Blood
Glucose Test Strips, Belgium, Average Price ($), Historic, 2000-2007 54
Figure 30: Blood Glucose Test Strips, Belgium, Average Price ($), Forecast,
2007-2012 55
Figure 31: Glucose Monitoring, Belgium, Distribution Share
(%), 2007 56
Figure 32: Glucose Monitoring, Belgium, Company Share (%),
2007 57
Figure 33: Insulin Delivery, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 58
Figure 34: Insulin Delivery, Belgium, Overall
Revenues ($ mn), Forecast, 2007-2012 59
Figure 35: Insulin Delivery,
Belgium, Revenue by Segment ($ mn), Historic, 2000-2007 60
Figure 36:
Insulin Delivery, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012
61
Figure 37: Insulin Pens, Belgium, Revenues ($ mn), Historic, 2000-2007
62
Figure 38: Insulin Pens, Belgium, Revenues ($ mn), Forecast, 2007-2012
63
Figure 39: Insulin Pumps, Belgium, Revenues ($ mn), Historic, 2000-2007
64
Figure 40: Insulin Pumps, Belgium, Revenues ($ mn), Forecast, 2007-2012
65
Figure 41: Insulin Syringes, Belgium, Revenues ($ mn), Historic,
2000-2007 66
Figure 42: Insulin Syringes, Belgium, Overall Revenues ($
mn), Forecast, 2007-2012 67
Figure 43: Insulin Syringes, Belgium, Volume
(Units), Historic, 2000-2007 69
Figure 44: Insulin Syringes, Belgium,
Volume (Units), Forecast, 2007-2012 70
Figure 45: Insulin Pens, Belgium,
Volume (Units), Historic, 2000-2007 71
Figure 46: Insulin Pens, Belgium,
Volume (Units), Forecast, 2007-2012 72
Figure 47: Insulin Pumps, Belgium,
Volume (Units), Historic, 2000-2007 73
Figure 48: Insulin Pumps, Belgium,
Volume (Units), Forecast, 2007-2012 74
Figure 49: Insulin Pens, Belgium,
Average Price ($), Historic, 2000-2007 75
Figure 50: Insulin Pens,
Belgium, Average Price ($), Forecast, 2007-2012 76
Figure 51: Insulin
Pumps, Belgium, Average Price ($), Historic, 2000-2007 77
Figure 52:
Insulin Pumps, Belgium, Average Price ($), Forecast, 2007-2012 78
Figure
53: Insulin Syringes, Belgium, Average Price ($), Historic, 2000-2007 79
Figure 54: Insulin Syringes, Belgium, Average Price ($), Forecast, 2007-2012
80
Figure 55: Insulin Delivery, Belgium, Distribution Share (%), 2007
81
Figure 56: Insulin Delivery, Belgium, Company Share (%), 2007 82
Figure 57: F. Hoffmann-La Roche Ltd., Value Chain Analysis 88
Figure
58: Abbott Laboratories, Value Chain Analysis 178
Figure 59:
Bayer HealthCare AG, Value Chain Analysis 255
Figure 60: Flowchart for
Classification of Non-invasive Devices in Belgium, 2007 279
Figure 61:
Flowchart for Classification of Invasive Devices in Belgium, 2007 280
Figure 62: Flowchart for Classification of Invasive Devices in Belgium, 2007
281
Figure 63: Flowchart for Classification of Invasive Devices in
Belgium, 2007 282
Figure 64: Flowchart for Classification of Invasive
Devices in Belgium, 2007 283
Figure 65: Flowchart for Classification of
Active Devices in Belgium, 2007 284
Figure 66: Flowchart for
Classification of Active Devices in Belgium, 2007 285
Figure 67: Flowchart
for Classification of Devices except Non-invasive, Invasive and Active Devices
in Belgium, 2007 286
Figure 68: Conformity Assessment of Class-I Medical
Devices in Belgium, 2007 287
Figure 69: Conformity Assessment of Class-IIa
Medical Devices in Belgium, 2007 288
Figure 70: Conformity Assessment of
Class-IIb Medical Devices in Belgium, 2007 289
Figure 71: Conformity
Assessment of Class-III Medical Devices in Belgium, 2007 290
Figure 72:
Global Markets Direct Methodology 294
|
